Castleman Disease in Practice—Recognizing, Classifying, and Treating a Rare Disorder

Overview:

Castleman disease (CD) is a rare group of lymphoproliferative disorders that can be difficult to recognize and classify due to symptoms that overlap with lymphoma, autoimmune diseases, and infections. As a result, diagnostic delays are common, and uncertainty remains regarding optimal treatment selection, particularly for multicentric forms of the disease.

This Cases and Conversations virtual webcast will use interactive patient cases and expert discussion to address key challenges in the diagnosis and management of CD. Faculty will review current evidence and guideline-based approaches for unicentric CD, HHV-8–associated multicentric CD, and idiopathic multicentric CD, with the goal of improving clinician confidence and patient care.

System requirements for the virtual activity are available here.

This event is free to all attendees.

Learning Objectives:

Upon completion of this activity, participants will be able to:

• Recognize the clinical, laboratory, and pathologic features that should prompt consideration of CD
• Differentiate unicentric CD from multicentric subtypes, including HHV-8–associated and iMCD, using appropriate diagnostic testing and clinical context
• Apply evidence-based and guideline-recommended treatment strategies for CD based on subtype, severity, and response to initial therapy

Target Audience:

This educational activity is directed toward physicians, hematologists, pathologists, dermatologists, nurses, NPs/PAs, pharmacists, and other HCPs involved in the diagnosis and treatment of hematological disorders.

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Physicians Education Resource^®, LLC is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This Application-based activity is approved for a maximum of 1.0 contact hour (1.0 CEU) under UAN # 0661-0000-26-022-L01-P.

Eligibility for credits requires full attendance, engagement in the live activity, completion and submission of activity evaluation, NABP e-pid# and month/date of birth within 30 days of activity completion. No partial credits are given.